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You’ve Just Been Bitten: An Introduction 
My foray into the world of global health was not subtle by any means. Over the course of 
a just few months during my junior year, I encountered the topic almost by chance and chose to 
dive in headfirst. At first, international health work was little more than a conversation topic in a 
class on Haiti and literature. The discussion lasted less than a week, but I was already hooked 
and craved to learn more.  
Soon after this initial conversation, I received the opportunity to meet with several 
founders of medical nongovernmental organizations (NGOs). Over dinner, a small group of 
students and I learned about their career paths and visions for their organizations in the future. In 
talking with these visionaries, I could clearly see the passion behind their endeavors and 
remember thinking to myself, I want that. I want to be so deeply invested in and passionate about 
my work that I can’t help but share my zeal with the world.  
My first taste at doing such impassioned work came on a medical service trip to Ecuador 
in January of 2013.  I was working as a student volunteer in mobile clinics throughout the 
Amazon Basin. This meant I was mostly doing the grunt work of recording patient histories, 
taking vitals, scribing for doctors, or counting pills in the pharmacy. Via these simple tasks, 
however, I began to see the true impact of the work we were doing.  
On most days, upwards of 100 people filtered through our makeshift clinics, and even in 
the masses, the humanity of each patient was never forgotten. During the course of the week, I 
learned to take pulses and temperatures with almost mechanical efficiency in order to keep pace. 
Once I reached the point where I no longer needed to think about the technicalities of the 
processes, my mind was free to engage with the patients themselves. Through the words, 
gestures, and expressions we exchanged, I began to comprehend a tiny bit of their lives.  
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I don’t know when it happened, but at some point that week I realized that this 
connection to our patients, this pure and uncensored human tie, was fuel for that passion I had 
wished for just months earlier. In that moment, I set my sights on working in global health. I 
have had ambitions of attending medical school for years. However, until my travels last year, a 
career in the field of medicine was a distant and comparatively vague plan. Now, armed with a 
cause, I have decided to focus my medical interests in international health, health equity, and 
public health; which brings me to this thesis.  
In Ecuador, my conversations with patients would occasionally drift to topics outside the 
usual realm of medicine. I learned of a cleansing ritual performed using an egg to heal the body 
and spirit, which is often called la limpieza. This, among other types of ceremonial healing I 
encountered, aroused a number of questions. How do different cultures, especially those in low-
income areas, view health and illness? How does this influence their views of foreign aid groups 
like us?  
Since this experience, I have developed few more questions with regard to this interface 
between traditional and modern medicine: How do Ecuadorian cultural views on disease diverge 
from those of contemporary modern medicine? What are the consequences that result from a 
clash or coexistence of distinct interpretations of health? How can we use diverse perspectives on 
disease to better understand the illness itself and the delivery of medical care in international 
situations?  
 
I will examine these questions through an in-depth study of one disease both in 
medicalized terms and in the cultural context of an endemic country. After combing through the 
plethora of diseases that plague low-income country in particular – where the Gross National 
 5 
Income per capita is $1,035 or less – I selected malaria in the rural Amazon Basin as my focus.1 
Not only is malaria still a problem in many areas of the world, it also presents a wide range of 
symptoms and can at times have psychosomatic effects. Thus, malaria lends itself well to a 
variety of different interpretations based upon cultural context and biomedical literacy. 
Furthermore, the Amazon Basin is home to an extremely impoverished and isolated indigenous 
population. Many communities throughout the region lack access to basic healthcare from the 
government, and instead they rely on local shamans or more recently foreign NGOs for all 
healthcare.  
 
The first section of this thesis will be a disease profile of malaria: its clinical presentation, 
treatment, and prevention. In beginning with a biomedical discussion of malaria, I seek to 
provide a sound basis through which the understanding of malaria held by the indigenous people 
of rural can be understood and analyzed.  
Next, I will present a case study of malaria in rural Amazon Basin region of Ecuador 
including an introduction to the cultural background of the area, the local perspectives on disease, 
and how indigenous population interacts with healthcare providers. This section is meant to set 
up the conflict of perception that occurs when outside medical providers – either foreign or 
Ecuadorian – bring modern medicine into a community where pills, blood tests, and shots are 
completely foreign concepts. 
Finally, I will end with an analysis of the challenges and advantages of this collision of 
medical cultures. In this section will including a series of recommendations for minimizing the 
negative effects and augmenting the benefits of a cross-cultural health clinic environment. 
                                                        
1 "How We Classify Countries." The World Bank. N.p., 2014. Web. 08 Jan. 2014. 
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Consequently, my case study of the Amazon Basin Ecuador can serve not only as one example 
of how divergent disease perceptions can affect efforts to combat disease, but can also act a 
model for strategies of cultural sensitivity that can be scaled up and used across varying cultures.  
Malaria is a complex disease that delivers a multifaceted collection of symptoms. While 
this is one of the reasons I chose it as a focus for this thesis, it is also the reason I must begin 
with a disease profile. Understanding the epidemiological, cultural and environmental effects of 
endemic malaria in a community begins with understanding the biomedical basis of the disease. 
This includes the parasite lifecycle, the effects of malaria on the body, current prevention 
strategies and the treatments used in western medicine. From this foundation, the disease can be 
better understood in the specific context of the Amazon Basin of Ecuador
Malaria: A Disease Profile 
 
Since 1957 in the United States, Malaria has existed only as a distant concern to all but 
travelers to the endemic areas of Sub-Saharan Africa, South America, or Southeast Asia. 
2
 In 
these endemic areas, however, it incessantly wreaks havoc in families, communities, and whole 
societies. Throughout the world, there are over 200 million cases of malaria annually resulting in 
over 600,000 deaths. About 80% of these deaths occur in just 14 countries and children and 
pregnant women are disproportionately affected. At one time, malaria was prevalent throughout 
the world, but now it is seen mostly in the subtropical areas of Africa, Asia, Central and South 
America. However, this still means that about almost half of the world’s population (3.3 billion 
people) is at risk for the disease.
3
  
Therefore, even though mortality rates for malaria have been falling since 2000, much 
work still remains to be done in order to get the disease under control. 
4
  While malaria, as one of 
the “Big Three” infectious diseases, has a healthy supply of funding from international sources 
such as the Global Fund, and private donors, such as Bill Gates, there remains debate on the best 
ways to use the available money. Additionally, the malaria parasites are becoming increasingly 
more resistant to some of the common antiparasitic drugs used today, necessitating further 
investment in the research and development of a new therapies.  
 Before we can look into treatment options being utilized around the world, we must 
understand how malaria infects its human host and is transmitted from one host to another. 
                                                        
2
 Zucker, Jane R., MD. "Changing Patterns of Autochthonous Malaria Transmission in the United States: A Review 
of Recent Outbreaks." Emerging Infectious Disease 2.1 (1996): 37-43. National Center for Biotechnology 
Information. Web.  
3
 Perkins, Douglas J., Tom Were, Gregory C. Davenport, James B. Hittner, and John M. Ong’echa. “Severe Malarial 
Anemia: Innate Immunity and Pathogenesis.” International Journal of Biological Sciences 7.9 (2011): 1427-442. 
National Center for Biotechnology Information. US National Library of Medicine, 2 Nov 2011. Web. 
4
 “Malaria.” World Health Organization Media Centre. World Health Organization, 2013. Web. 
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Knowledge of the mechanisms of infection and transmission of malaria, though complex, is 
crucial for identifying targets for potential drugs, vaccines, or other therapies.  
 There are four malaria strains known to cause illness when transmitted to humans. They 
are Plasmodium falciparum, the deadliest and most common strain, Plasmodium vivax, another 
very common strain that is less well understood, Plasmodium malariae, and Plasmodium ovale. 
All strains of Plasmodium parasites are transmitted to humans via the vector of the Anopheles 
mosquito. Of the twenty different species of Anopheles mosquito most bite almost exclusively at 
night – hence the effectiveness of using bed nets to prevent malaria – and breed in standing 
water.
5
 My focus will remain on P. falciparum and P. Vivax for the most part since they are the 
two most prevalent strains. These two stains are similar in many ways, so I will first explain the 
lifecycle, pathology, treatments, and complications of P. falciparum, which are more intimately 
understood. Then, I will highlight the differences that exist in the characterization and 
mechanism of P. vivax, as there are some very important ones.  
 Because the Plasmodium parasites rely on mosquitos as a vector, environmental 
conditions that affect mosquito survival also have an impact on the intensity and extent of 
malaria infections. Some of these factors include rainfall patterns, temperature and humidity, and 
seasonal changes.
6
 Another influence on infection rates is the development of human immunity 
to malaria. In areas of moderate or high transmission, partial immunity and immunity to the 
common symptoms of malaria are built up over time due to repeat infections. This is why the 
most serious, life-threatening infections occur in children under 5 years old, those who are under 
nourished, or those who are immunocompromised. Though this adaptive immunity does provide 
                                                        
5
 Perkins, Douglas J., Tom Were, Gregory C. Davenport, James B. Hittner, and John M. Ong’echa. “Severe Malarial 
Anemia: Innate Immunity and Pathogenesis.” International Journal of Biological Sciences 7.9 (2011): 1427-442. 
National Center for Biotechnology Information. US National Library. 
6
 Ibid. 
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some protection for the individual from the effects of sever symptoms, it does stop transmission 
of the parasite.   
 
The Lifecycle of the Malaria Parasite 
 A malaria infection by begins with the injection of P. falciparum sporozoites, a spore-like 
stage of the parasite’s lifecycle, into a human host by way of a female Anopheles during a blood 
meal. The sporozoites the briefly circulate in the bloodstream before entering hepatocytes or 
liver cells. Sporozoites will reside here for the next 7-15 days.
7
 This is called the incubation 
period – the time between initial infection and the presentation of symptoms. While in the 
hepatocytes, P. falciparum grow, divide, and produce haploid merozoites, which are able to 
invade red blood cells – also called erythrocytes. 
 Once merozoite production causes hepatocytes to rupture and the parasites are dumped 
into the bloodstream, they begin infecting erythrocytes. Inside the red blood cells, the merozoites 
undergo a type of asexual replication called schizogony.  In schizogony, merozoite undergoes 
nuclear division several times resulting in many daughter nuclei contained within the cytoplasm 
creating what is called a schizont. When the schizont cytoplasm divides, around 12-16 new 
merozoites are formed.
8
 This asexual replication continues until the erythrocyte bursts and 
releases all the daughter merozoites into the blood, which can infect more erythrocytes 
continuing the cycle.  
The classic malarial symptoms of cyclical fever and chills are associated with the 
periodic and synchronous release of merozoites, which signals the release of cytokines – cell 
                                                        
7
 “Malaria.” Life Cycle of the Parasite. National Institute of Allergy and Disease, 3 Apr. 2012. Web.  
8
 “Malaria” Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 08 Feb. 2010.  
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signaling molecules – TNF α and Interleukin–1 causing an inflammation response.9  Another 
complication arises when erythrocytes that have been parasitized but not yet lysed are 
sequestered or adhere to the endothelial cells in the narrow capillaries of various organs.
10
 
Adhesion is thought to be a result of modifications to the erythrocyte membrane induced by the 
presence of the merozoites. Sequestration usually only occurs in advanced stages of infection and 
contributes to the fatality of severe malaria in affected individuals.  
 
Parasite Lifecycle: There are two separate stages in the complete lifecycle involving 
both human and mosquito. Additionally, there is a sub cycle in the human blood stage 
causing the development of malaria
11
 
 
Some merozoites break the blood stage cycle and instead, develop into sexual male and 
female gametocytes that circulate freely in the bloodstream and are injected by a new mosquito 
during a blood meal. These gametocytes are precursors to the sexual forms of P. falciparum 
                                                        
9
 Miller, Louis H., Michael F. Good, and Genevieve Milon. “Malaria Pathogenesis.” Science 264 (1994): 1878-863. 
Science Magazine. AAAS. Web.  
10
 Haldar, Kasturi, Sean C. Murphy, Dan A. Milner, Jr., and Terrie E. Taylor. “Malaria: Mechanisms of Erythrocyte 
Infection and Pathological Correlates of Severe Disease.” Annual Review of Pathology: Mechanisms of Disease 2 
(2006): 217-49. Annual Review of Pathology. Annual Reviews, 2007. Web.  
11
 Fazekas, Balazs. "An Eradicating Vaccine for Plasmodium Falciparum: Possibility or Pipe-dream?" Cambridge 
Medicine Journal 37 (2011): n. pag. Web. 
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(gametes) that develop in the stomach of the mosquito and are carried again as sporozoites to the 
next human host. 
12
  
The traditional clinical presentation of malaria is best defined by its cyclical pattern of 
fever and chills driven by the erythrocyte stage of the infection. These symptoms can be 
accompanied by fatigue, nausea and headaches that vary in intensity. Treatment is most effective 
at this point in the infection, but in many malaria endemic regions is not usually easily accessible. 
If the infection becomes severe, a patient can develop hypoglycemia or low blood sugar; lactic 
acidosis – the buildup of lactic acid due to liver failure; anemia – a deficiency of healthy red 
blood cells to deliver oxygen and nutrients to body tissues; and altered consciousness.
13
 Factors 
determining the development of severe malaria complications are complex and include 
interactions between the patient’s immune responsiveness, parasite strain, environmental 
conditions, and age at infection among others.  
 
Pathologies of Severe Malarial Complications 
 Cerebral malaria is the best-studied and most serious form of severe malaria mostly 
because it is a factor in a majority of malaria deaths. While there are many theories that deal with 
its causes, a main component of the development of this severe complication is likely the 
sequestration of parasitized erythrocytes in the brain, which causes obstruction of the small but 
vital blood vessels surrounding the brain. Although the relationship between sequestration in the 
brain and cerebral malaria remains indirect at the moment, it is thought that the obstruction of 
blood flow leads to hypoxia, reduction of metabolite exchange, and the release of inflammatory 
                                                        
12
 “Malaria.” Life Cycle of the Parasite. National Institute of Allergy and Disease, 3 Apr. 2012. Web.  
13
 Haldar, Kasturi, Sean C. Murphy, Dan A. Milner, Jr., and Terrie E. Taylor. “Malaria: Mechanisms of Erythrocyte 
Infection and Pathological Correlates of Severe Disease.” Annual Review of Pathology: Mechanisms of Disease 2 
(2006): 217-49. Annual Review of Pathology. Annual Reviews, 2007. Web.  
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mediators all causing damage to the surrounding tissue.
14
 A diagnosis of cerebral malaria in 
practice is non-specific and based on the presence of systematic severe malaria symptoms along 
with altered consciousness, seizures, retinal changes and in the most extreme cases coma.  
Clinically, those with cerebral malaria – most often young children – exhibit extremely 
high concentrations of parasites circulating in the bloodstream as well as elevated levels of TNF 
α and other inflammatory cytokines in cerebral tissues. These cytokines recruit immune cells to 
attack the parasite. However, in the process they also damage surrounding host tissue. A 
combination of this inflammatory stress and anoxia due to the adherence of erythrocytes to 
endothelial walls leads to the cerebral damage. Discernible signs of damage during a comatose 
state can be brain swelling, intra cranial hypertension, retinal changes and damage, and 
abnormalities in brain stem controlled functions such as posture, pupil size and reactivity, and 
respiratory patterns.
15
 Additionally, systemic effects can include worsened anemia, metabolic 
acidosis, electrolyte imbalance, fever, hypoglycemia and some cases seizures. These symptoms 
are indicative of systemic shock due to both the presence of a pathogen in the blood as well as 
inflammation, oxygen depletion, and damage in the brain. 
 Without treatment, cerebral malaria is almost always fatal, and even when treatment is 
given, up to 30 percent of children who progress to the cerebral stage still die. Furthermore, in 
those who survive cerebral malaria about 10 percent are likely to be permanently disabled.
16
 
Since young children are those most likely to develop cerebral malaria and other complications, 
                                                        
14
 Mackintosh, Claire L., James G. Beeson, and Kevin Marsh. “Clinical Features and Pathogenesis of Sever 
Malaria.” Trends in Parasitology 11.12 (2004): 597-603. Science Direct. Elsevier B. V. Web.  
15
 Idro, Richard, Kevin Marsh, Chandy C. John, and Charles RJ Newton. “Cerebral Malaria; Mechanisms of Brain 
Injury and Strategies for Improved Neuro-Cognitive Outcome.” Pediatric Research 68 (2010): 267-74. Nature. 
Nature Publishing Group, 2010. Web. 
16
 Idro, Richard, Kevin Marsh, Chandy C. John, and Charles RJ Newton. “Cerebral Malaria; Mechanisms of Brain 
Injury and Strategies for Improved Neuro-Cognitive Outcome.” Pediatric Research 68 (2010): 267-74. Nature. 
Nature Publishing Group, 2010. Web. 
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these permanent disabilities and loss of life can be devastating not only for a family, but also for 
the entire community.  
 Brain damage sustained by children who survive cerebral malaria can include blindness; 
ataxia – uncoordinated movement; central hypotonia – poor muscle tone; epilepsy; and impaired 
cognition, speech/language, and motor function.
17
 These effects vary depending on the region of 
the brain in which sequestration occurs, severity of the inflammatory response, and other factors 
associated with individual variation in brains. Also, unfortunately, since cerebral malaria is so 
often fatal, few studies have focused on rehabilitation for children with malaria associated 
cerebral damage. If malaria treatment effectiveness improves, the need for rehabilitation through 
physical, occupational, behavior, and speech therapy in endemic regions will likely rise as well 
with more children surviving bouts of severe malaria.  
 Another major source of mortality within malaria infections is malarial anemia, which is 
generally defined as a reduction in hemoglobin (the oxygen carrying protein present in 
erythrocytes) levels below 11.0 g/dL.
18
 Although it does have a lower case fatality rate than 
cerebral malaria – about 10 percent – its incidence rate is much higher. Especially in areas where 
nutritional and immunological deficiencies in infants, youth, and pregnancies are common, 
malarial anemia can be devastating. Additionally, in malaria endemic areas, blood transfusion, 
which can be life saving in the case of malarial anemia, are either unavailable, or not easily 
accessible.  
                                                        
17
 Idro, Richard, Kevin Marsh, Chandy C. John, and Charles RJ Newton. “Cerebral Malaria; Mechanisms of Brain 
Injury and Strategies for Improved Neuro-Cognitive Outcome.” Pediatric Research 68 (2010): 267-74. Nature. 
Nature Publishing Group, 2010. Web. 
18
 Haldar, Kasturi, Sean C. Murphy, Dan A. Milner, Jr., and Terrie E. Taylor. “Malaria: Mechanisms of Erythrocyte 
Infection and Pathological Correlates of Severe Disease.” Annual Review of Pathology: Mechanisms of Disease 2 
(2006): 217-49. Annual Review of Pathology. Annual Reviews, 2007. Web.  
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Like in cerebral malaria, the precise mechanisms of malarial anemia are uncertain. 
However, two major causes are likely the lysis of uninfected erythrocytes along with infected 
ones and the decrease in formation of blood components due to the overexpression of cytokines.  
The clearance of both uninfected red blood cells may be in part due to the deposition of 
parasite ligands on the surface of the unaffected cells by affected cells. This tagging then results 
in their clearance from circulation by sequestration in the spleen.  Another proposed factor in 
erythrocyte clearance could be linked to oxidative damage or other subtle alterations to the 
plasma membrane of healthy cells.
19
 It is also important to note that development and severity of 
malarial anemia is not only dependent on the concentration of parasites in the blood, but also on 
subtle effects such as these to healthy blood cells and individual immune strength.  
The other major contributor to malarial anemia, especially in children, is suppression of 
bone marrow resulting in impaired erythropoiesis (generation of new erythrocytes). Loss of the 
ability to produce new erythrocytes then translates to an inability to compensate for the loss of 
infected red blood cells. Studies of patients with severe malarial anemia show significant 
structural damage to bone marrow, reduction of erythropoietic (erythrocyte precursor) 
production, and excessive growth of immature and abnormal erythroid precursors.
20
 The 
combination of these findings demonstrates a link between the reduction of erythropoiesis due to 
bone marrow damage and the aggravation of malarial anemia.  
Damage to bone marrow as a result of a severe P. falciparum infection has not been 
completely pinned down to a single source, but an imbalance of inflammatory signals appears to 
                                                        
19
  Haldar, Kasturi, Sean C. Murphy, Dan A. Milner, Jr., and Terrie E. Taylor. “Malaria: Mechanisms of Erythrocyte 
Infection and Pathological Correlates of Severe Disease.” Annual Review of Pathology: Mechanisms of Disease 2 
(2006): 217-49. Annual Review of Pathology. Annual Reviews, 2007. Web. 
20
 Perkins, Douglas J., Tom Were, Gregory C. Davenport, James B. Hittner, and John M. Ong’echa. “Severe 
Malarial Anemia: Innate Immunity and Pathogenesis.” International Journal of Biological Sciences 7.9 (2011): 
1427-442. National Center for Biotechnology Information. US National Library 
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play a major role. During the immune response to P. falciparum infection, the body produces an 
abundance of both pro- and anti- inflammatory mediators including cytokines, chemokines, 
growth factors, and effector molecules as an attempt to control parasitemia. The release of these 
inflammatory factors is extremely time sensitive, and can either successfully regulate parasite 
levels, or conversely, can induce damage in host tissues including bone marrow.   
 Both cerebral malaria and malarial anemia are major contributors to the death toll of P. 
falciparum. While experts don’t completely understand the mechanisms behind why severe 
malaria complications develop only in some patients, they do have an idea of the general factors 
involved. The main contributors to both cerebral malaria and malarial anemia seem to be 
parasitemia or very high concentration of parasites in the blood, and the effects of excess 
cytokine release, which causes damage to host cells but is unable to summon a sufficient immune 
response 
 
Malaria in Pregnancy 
 There are several reasons malaria is exceptionally dangerous to pregnant women as well 
as young children. One of the biggest involves their need for extra resources in order to support 
the healthy growth of the fetus. Many times in low-income areas, they are malnourished which 
leaves them more vulnerable to disease. Therefore, pregnant women are often affected by severe 
malarial complications for very different reasons than young children who are the other main 
victims of serious disease. In general, pregnant women, have a higher incidence of anemia or 
insufficient amounts of erythrocytes in the blood. This preexisting anemia results in a higher 
likelihood of succumbing to severe malarial anemia if infected.  
 16 
 Additionally, a malarial infection during pregnancy presents the risk of sequestration of 
parasite-infested erythrocytes in the placental blood vessels. Such an even then can result in fetal 
growth retardation and premature delivery in addition to a decline in maternal health.  
 
Treatments  
 The first widely used effective treatment for malaria was quinine, a compound naturally 
found in the bark of cinchona tree and first discovered by the Quechua people of Ecuador, Peru 
and Bolivia.
21
 Quinine was subsequently the antimalarial drug of choice until the 1940’s when 
new drugs, such as the quinine derivative, chloroquine, harboring less unpleasant side effects 
began replacing it in treatments. However, in critical situations, such as severe and cerebral 
malaria, quinine is still used. In general, quinine is an antipyretic, meaning it is used to prevent 
or reduce fevers, and an analgesic or pain reliever that can be given in oral form or as an 
intramuscular injection.
22
  
Initially, the Quechua used ground bark of the cinchona trees mixed with sweet water, 
which produced what we now know as tonic water, in order to halt shivering.
23
 After they 
introduced European explorers to this treatment, it was brought back to Europe and first 
officially used to treat malaria in 1631.
24
 Though the connection originally made between the 
shivers quinine was originally used to treat and the shivers occurring as a symptom of malaria 
was incorrect, quinine was still successful as a treatment. Then, in the 1930’s a derivative of 
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 Toovey, Stephen. “The Miraculous Fever-Tree. The Cure That Changed the World.”  Travel Medicine and 
Infectious Disease 2.2 (2004): 109-10. Print. 
22
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23
  Flückliger, Friedrich A., and Daniel Hanbury. Ptharmacographia: A History of the Prinicpal Drugs of Vegetable 
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 Toovey, Stephen. “The iraculous Fever-Tree. The Cure That Changed the World.”  Travel Medicine and 
Infectious Disease 2.2 (2004): 109-10. Print. 
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quinine called chloroquine quickly became the preferred antimalarial drug. Though still toxic at 
higher doses, it is slightly safer than pure quinine.  
Interestingly, it is the oldest of the known treatments for malaria, the mechanism of 
action for quinine and its derivatives against P. falciparum are still unknown. The most widely 
agreed upon model involves quinine acting as an inhibitor of heme breakdown inside the parasite. 
Due to the fact that its structure contains multiple amines – in the figure below, these are the two 
nitrogens (N) in each compound – quinine preferentially accumulates in the lysosomal 
compartment of the parasite where it inhibits proper heme breakdown by the parasite leading to 
the accumulation at toxic levels of bilirubin, partially degraded heme. This buildup then 
ultimately stimulates apoptosis or programmed cell death.
25
  
 
Quinine and Derivatives: Chemical structure for the antimalarial 
compound quinine, which was isolated from the cinchona tree, is 
depicted on the left. Two of its synthetic derivatives are on the right
26
 
 
Unfortunately, as mentioned earlier, quinine in therapeutic doses has the potential to 
cause serious adverse side effects. The main complication sited in conjunction with quinine 
treatment is the development of cinchonism, which is a syndrome caused by the accumulation of 
toxic levels of cinchona alkaloids in the body. Its symptoms can range from mild blurred vision, 
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 “Quinine (DB00468).” Drug Bank. The Metabolomics Innovation Centre, 2013. Web. 
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nausea, weakness, and vertigo to more serious hypotension, premature ventricular contractions 
and in the most severe cases cardiac arrest.
27
 Due to these potentially serious side effects, once 
new medications based on a different herbal derivate artemisinin were discovered to be more 
effective with less of the severe side effects, quinine was relegated to treatment of only the most 
severe malaria. Even the safer derivatives of quinine – namely chloroquine, which was until the 
1990’s the most widely used malaria treatment – are now used only sparingly compared to newer 
treatments.  
Since the early 2000’s the gold standard for malaria treatment worldwide has been 
artemisinin based combination therapy (ACT), which combines several antimalarial drugs in 
order to prevent the development of drug resistance. The core component of the treatment is 
artemisinin, is isolated from Artemisia annua, a sweet wormwood herb that has been used for 
over two thousand years in traditional Chinese medicine. Its effectiveness against malaria was 
discovered as part of a 1972 study including the evaluation of over 5000 traditional Chinese 
medicines. Artemisinin was found to be not only effective, but also able to clear malaria 
parasites from the body faster than any known drug.
28
 One concern with the drug however, was 
its potential structural instability.  
The effectiveness of artemisinin is derived from its structure, however. The chemical is a 
sesquiterpene with a rare peroxide bridge – a direct bond of two oxygens to one another, which is 
the cause of its unique antimalarial qualities. The endoperoxide linkage between oxygens acts a 
trigger for the molecule to explode in the presence of infected erythrocytes. One major proposal 
for the activation of artemisinin is reduction by iron contained within the malaria parasites.  
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Artemisinin and Derivatives: The chemical structure of artemisinin is on 
left, and the structures of two of its synthetic derivatives are on the right 
 
When the peroxide bridge comes in contact with iron (II), it is cleaved and releases 
highly reactive radical oxo-iron species, which then proceed to destroy the parasite through 
disruption of redox homeostasis. Artemisinin targets only erythrocytes infected by malaria 
because these cells have a sustained pool of iron (II) that were once a part of hemoglobin. During 
the invasion of an erythrocyte, malaria merozoites consume and digest hemoglobin releasing the 
heme (iron) group. These iron atoms are then able to directly reduce the peroxide bond causing 
the activation of the artemisinin “bomb” and subsequent oxidative damage.29  
 Despite the many structural advantages to using artemisinin for malaria treatment, one 
significant obstacle was the compound’s poor solubility in both water and oil. This property 
severely limited deliverability of the drug. Therefore, instead of using pure artemisinin, 
treatments today utilize derivatives of the compound that still maintain the crucial peroxide 
bridge, but also have improved bioavailability.
30
 Another branch of research is currently looking 
into synthetic products with similar antimalarial properties as artemisinin.  
One of those synthetics is called artesunate. It is a water-soluble derivative of artemisinin. 
This means that it can be given as an intravenous injection, which are more effective and faster 
acting than a pill form of the drug. Artesunate has been shown to be more effective at preventing 
                                                        
29
 Brown, Geoff. “Artemisinin and a New Generation of Antimalarial Drugs.” Education in Chemistry (2006): 
Royal Society of Chemistry. Royal Society of Chemistry, July 2006. Web. 
30
 Brown, Geoff. “Artemisinin and a New Generation of Antimalarial Drugs.” Education in Chemistry (2006): 
Royal Society of Chemistry. Royal Society of Chemistry, July 2006. Web. 
 20 
deaths from severe malaria than quinine through several randomized control trials, It has quickly 
become the recommended first line treatment for severe in adults and is currently being tested in 
children.
31
  
In structural terms, the major difference between artemisinin (along with many of the 
other artemisinin derivatives) and artesunate is the addition of a succinic acid to the lactone ring. 
This addition of a hydrophilic (water-loving) side chain allows the drug to mix well with water 
and travel through the blood effectively. This is a major breakthrough in malaria treatment as the 
insolubility of antimalarial compounds has been one of the biggest challenges in the fight against 
malaria.  
 In order to combat drug resistance in P. falciparum, all types of artemisinin treatments 
often contain other antimalarial compounds. Artemisinin, as the fastest and most effective 
antimalarial, acts quickly to eradicate a majority of the parasites. Then, the other slower partner 
drugs eliminate any remaining parasites. This ensures that if by chance the artemisinin-based 
drug doesn’t kill a few parasites, they don’t survive to reproduce and create more resistant 
parasites.  
 
The Emergence of Drug Resistance in P. falciparum 
 Though significant efforts have been made to minimize the development of drug 
resistance in malaria strains through the use of combination therapies and strict treatment 
regimens, the problem is a very real one. Since the introduction of chloroquine (CQ) as the main 
antimalarial treatment in the 1950’s, a CQ resistant mutant of P. falciparum has been spreading 
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rapidly through malaria endemic regions.
32
 Resistance developed so quickly due to the practice 
of monotherapy or using only one drug to treat patients. For this reason, the World Health 
Organization (WHO) now recommends combination therapies for treatment of malaria.  
 While most strains of P. falciparum are still sensitive to the artemisinin-based drugs are 
more expensive to manufacture making the wide distribution necessary to fight the spread of the 
disease challenging and imposing large societal costs in the process. Even more concerning is the 
fact that in several countries in the Greater Mekong sub-region of Southeast Asia, artemisinin 
resistance of P. falciparum have been detected.
33
 The spread of such resistance to other endemic 
areas could mean the loss of recent, hard-earned gains in the fight against malaria. This is 
because as of yet, there are no alternative antimalarial medicines available, and furthermore, it 
will be at the very least a few decades for the development, testing and approval of a new 
treatment if one can be found.
34
  
Therefore, a public health driven movement to avoid the development of resistance to our 
best treatment option has also been in progress. This movement utilizes a combination of disease 
ecology, epidemiology, genetics, and evolutionary biology in order to track the evolution of the 
parasite and the dynamics of its spread throughout populations.
35
 Hopefully, such an effort will 
prevent the need to search for novel drugs to fight malaria and the focus can stay on utilizing the 
tools we have in the most effective ways.  
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Prevention 
 On the other side of the fight, there are two major forms of prevention, which are used in 
most countries where P. falciparum is endemic. The first is the use of insecticide-treated 
mosquito nets. They have been touted as a miracle for the cost effective prevention of malaria, 
and if used properly can be just that. These nets are most often provided for free or for a small 
fee to those in high-risk areas and are effective at keeping the Anopheles mosquitos, which are 
usually most active in the evenings and at night, at bay. The other widely used prevention 
strategy is indoor spraying with residual insecticides. This method can be very effective if at 
least 80 percent of the houses in an area are sprayed, and can last for up to 9-12 months in some 
cases.
36
 Both of these prevention methods are in use in many endemic areas, but full coverage is 
proving to be quite challenging due to the inaccessibility of some at risk populations and the 
difficulty of ensuring complete and proper compliance regarding the use of these prevention 
strategies. 
 The difficulty of full utilization of current prevention techniques has also contributed to a 
push to find a vaccine that could produce immunity to the P. falciparum parasite. This approach 
has not been without its own obstacles, however, many of which are derived from the complexity 
of the parasite life cycle. Unlike many bacterial or viral infections, parasites have many different 
forms they take on in the human body and its life cycle in the human body is also less well 
understood. This makes it challenging to develop a vaccine that will correctly elicit the 
immunological memory, which will allow the body to recognize and fight P. falciparum before it 
takes hold in the erythrocytes.  
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 Scientists have been in search of a viable vaccine since the early 20
th
 century. Many early 
attempts mimicked those used to create the first vaccines to bacteria and viruses involving the 
injection of malaria sporozoites, which had been inactivated by formalin, a 40 percent 
formaldehyde solution.
37
 Although these sporozoites are the form in which the body first 
encounters P. falciparum in a natural infection, it failed to produce immunity in tested subjects. 
In retrospect, this vaccine was developed before in was known that the parasite had a liver stage 
and that the liver stage was crucial for triggering the immune response. 
 Since we have learned more about the intricate life cycle of P. falciparum, research on a 
malaria vaccine has shifted in order to better activate the immune system in the same way the 
virus would. Research has also diverged into two camps as techniques for creating more 
advanced and safer vaccines have arisen in the past 30 years. 
 One branch has pursued the creation of a subunit vaccine against malaria. A subunit 
vaccine is one made up not of an entire pathogen, but rather, only of the specific antigens on that 
pathogen that elicit the best immune response.
38
 In this case, an antigen is most often a specific 
protein bound to the surface of the pathogen, which immune cells will bind with and recognize 
as foreign starting a cascade of responses. Any pathogen will have many different antigens on it 
with eliciting stronger immune reactions than others. These subunit vaccines reduce the chance 
of any adverse reaction and completely eliminate the chance of contracting the disease from its 
vaccine.   
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 Currently, the best candidate of many subunit vaccines being tested is called RTS,S, 
which is based off the protein coat on the sporozoite that initially infects humans.
39
 Researchers 
hope that with the use of this vaccine, immunized patients will develop antibodies for the 
specific proteins present on malaria sporozoites. Then, if infected, their immune system will 
recognize the proteins on the sporozoite coat and elicit a stronger and quicker response to the 
parasite than an unimmunized patient would. This vaccine is currently in phase III clinical trials 
in various malaria endemic countries in Africa and is showing promise. However, this approach 
is far from perfect. Two caveats for the RTS,S vaccine are its efficacy and the duration of 
protection.  
First of all, its efficacy is only 30 – 50 percent, meaning only that percentage of subjects 
who received the vaccine was protected against a later challenge infection. Additionally, the 
protection delivered by the RTS,S vaccine appears to last at maximum only 3 months.
40
 While 
this is does mean that some people who received the vaccine would indeed be protected for a 
time, it is uncertain whether this relatively low protection rate is worth the time, money, and man 
power needed to distribute the vaccine through endemic regions.  
The other branch of malaria vaccine research is revisiting an approach that was initially 
developed over 30 years ago in 1967. This original approach used irradiated sporozoites from the 
salivary glands of irradiated mosquitoes to induce an immune response in mice without the 
acquisition of malaria by the mice.
41
 The irradiation inactivated the parasites without altering the 
structure of their surface proteins like other methods of inactivation such as heat or chemicals do. 
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This allows for an immune response to develop against antigens, as they are present on the live 
parasite.
42
 Findings were promising, but the approach was soon abandoned due to the rise in 
popularity of the safer subunit vaccine. 
Now, researchers revisiting the irradiated sporozoite method have added a slight twist to 
the method in hopes of eliciting an even stronger immune response. In addition to irradiating 
both the mosquitoes and sporozoites to ensure safety of the vaccine, researchers are obtaining the 
sporozoites through careful manual dissection of mosquito salivary glands and preserving them 
via cryopreservation or cooling to sub zero temperatures to maintain the viability and 
effectiveness of the sporozoites.
43
 Also, in addition to the typical intradermal and subcutaneous 
injections, they tested the effectiveness of intravenous injections of the vaccine. It turns out that 
the intravenous injections provided a superior antibody and T cell responses including the 
development of memory T cells, which is the critical component to adaptive immunity against a 
pathogen. 
T cell response was also correlated with protection from a challenge infection induced 
three weeks after immunization. In those who were given the highest doses of irradiated 
sporozoites, all volunteers were protected and showed the highest levels of antibodies and CD4 
and CD8 T cells. In the group given the next highest dose, six out of the nine volunteers were 
protected and had slightly lower but still significant levels of antibodies, and both types of T 
cells.
44
 These encouraging results highlight the major advantage of using whole parasites as 
                                                        
42
 National Institute of Health. Radiation-Killed Bacteria Vaccine Induecs Broad Immune Response in Mice. 
National Institute of Allergy and Infectious Disease. National Institute of Health, 25 July 2006. Web.  
43
 Good, M. F. "Pasteur Approach to a Malaria Vaccine May Take the Lead." Science341.6152 (2013): 1352-353. 
Print. 
44
 Good, M. F. "Pasteur Approach to a Malaria Vaccine May Take the Lead." Science341.6152 (2013): 1352-353. 
Print. 
 26 
opposed to just protein subunits. Basically, all 1,000+ antigens expressed on the surface of the 
malaria parasite become potential targets for an immune reaction.  
The irradiated sporozoite method is not without its drawbacks, however. One major 
downside is that in the study, more than 600,000 sporozoites per subject were required to induce 
complete immunity.
45
 This, combined with the fact that each infected mosquito contains at most 
a few hundred thousand sporozoites means that mass production of the vaccine could be tricky 
and time intensive. Furthermore, the effectiveness of the vaccine against multiple different 
strains of P. falciparum as well as the duration of immunity both remain to be tested. Without 
these statistics, it is impossible to effectively and efficiently implement a vaccine centered 
prevention strategy. Finally, since the vaccine must be given intravenously for maximum success, 
concerns exist about compliance in areas where it is hard enough to get people to come to health 
clinics in the first place.  
A proper vaccine could dramatically shift the tide in the fight against malaria especially if 
executed in conjunction with already proven prevention methods. However, while there are 
multiple promising avenues being explored in development of a malaria vaccine, operational and 
successful implementation of such a prevention strategy is at least a decade or more away.  
 
Plasmodium vivax: What’s so different about it? 
 Now to switch gears a little, there is another species of malaria that is particularly 
relevant to the global fight against the parasite. Although it has at times been called the “benign 
malaria”, Plasmodium vivax is nothing to be taken lightly. In fact, this minimization of the 
disease has likely done more harm than good. Although P. falciparum does deserve a great deal 
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of attention due to its lethality – 90 percent of malaria deaths worldwide are due to P. falciparum 
– the costs of neglecting research and development on P. vivax are becoming ever more apparent 
as we inch closer to the possibility of the eradication of malaria.
46
 In numerous studies conducted 
over the past few years, as the overall number of cases of malaria begins to fall in a certain 
region, the proportion of cases due to P. vivax increases.
4748
 This suggests that there is likely 
something different about the infection strategy of P. vivax, which could prove potential 
problematic for the campaign to eradicate malaria. If we continue to use the same strategies that 
don’t appear to be working against vivax, we may end up with a very different situation in a few 
years.  
 It is estimated that around 2.6 billion people per year are at risk for contracting P. vivax 
malaria.
49
 This large number is partially due to the fact that unlike P. falciparum, which is 
carried by only a limited number of mosquito species, P. vivax is carried by at least 71 species. A 
number of these species are quite comfortable in temperate climates as well as more tropical 
climates meaning that they have the potential to spread to areas such as Europe and the United 
States. Additionally, many of these species are active during the day as well as at night, negating 
some of the beneficial aspects of prevention strategies such as bed nets.
50
 So, while this species 
of malaria may not have the eye-catching kill times or overwhelming lethality rates, it certainly 
is a problem in very different ways.  
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 In many ways, both P. falciparum and P. vivax are very similar. The main acute 
symptoms of both are fever and chills, headache, and vomiting. Both also attack and eventually 
lyse erythrocytes leading to anemia in their victims. Finally, though they share the same general 
life cycle of merozoite to trophozoite to gametocyte in the mosquito and back to merozoites 
again in a different human host, there are a few major differences that set P vivax apart from P. 
falciparum.  
One major difference exists in the cells invaded by the two species. P. vivax will 
preferentially invade reticulocytes, or immature red blood cells making P. vivax infections harder 
to diagnose since reticulocytes are present at much lower concentrations in the blood than adult 
erythrocytes. This selection of reticulocytes over mature erythrocytes in the infection stage could 
help to explain some of subtler and delayed symptoms of P. vivax in comparison to P. 
falciparum. 
Another defining factor that separates P. vivax is that the red blood cells remain pliable 
unlike in a P. falciparum infection where they becomes rigid leading to accumulation in the 
capillaries or segregation.
51
 Since accumulation of infected cells is one of the major contributors 
to the development of cerebral malaria, the lack of accumulation could contribute to the lower 
lethality of P. vivax.    
 Most notably, though, the life cycle of P. vivax includes a dormant hypnozoite stage in 
the liver.
52
 Therefore, in addition to producing a similar acute blood infection to that of P. 
falciparum, P vivax parasites also have the option of remaining in the liver for a time then 
reemerging later resulting in a relapse of symptoms. These relapses can come anywhere between 
months and years after symptoms from the initial infection have disappeared and with no 
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evidence of reinfection.
53
 A relapse is not to be confused with recrudescence, which is a return of 
malaria within days or weeks of treatment and is a result of inadequate clearance of the parasite 
from the blood.  
These hypnozoites are a key characteristic of P. vivax. They are usually 5 μm in diameter 
(the equivalent of five thousandths of a millimeter), are visible at about 36-40 hours after 
sporozoite inoculation and will remain fundamentally unchanged throughout their dormancy 
stage.
54
 One of the biggest reasons the hypnozoite is such a problem in P. vivax infections is 
because almost every major antimalarial medicine in use today, is designed to attack the blood 
stage parasites. Since in P. vivax infections, there are some parasites that stay hidden in the liver 
during the initial infection, they will be able to reemerge and begin a relapse episode at a later 
time, likely after the patient has already gone through treatment and recovered. This cycle can 
keep happening in those with P. vivax infections leading to complications such as susceptibility 
to other diseases or malnutrition related deficiencies, chronic anemia, and can affect ability to 
work.  
Additionally, each successive relapse comes with the possibility of a strengthened 
parasite. With its time in the liver, where it is effectively hidden from the immune system, P. 
vivax has the potential to take a greater hold in the body with each relapse that occurs.
55
 This 
adds support to the saying acknowledged by many in the public health community that 
“Falciparum kills you fast while vivax kills you slowly”.  
To add to the complications of controlling and treating P. vivax malaria, this species of 
the parasite is able to population the blood stream before symptoms begin to show at around two 
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weeks post bite.
56
 This means that by the time a case is noticed and reported, P. vivax could 
already be endemic in the area, especially if the area of concern is a small close community.  
 All of these subtle but crucial differences between P. falciparum and P. vivax can help to 
explain why they exhibit such different infection strategies and can also give us a window into 
how to combat the lesser known but equally dangerous P. vivax.  
 
Treatments for P. Vivax 
Until recently there has not been much of a focus on understanding or combatting the so-
called “slow killer” since the 1950’s. Nevertheless, developments have been made in creating 
drugs to destroy the hypnozoite and in finding better ways to track the prevalence rates of P. 
vivax infections as separate from P. falciparum.  
Firstly, blood stage P. vivax infections are completely treatable. This parasite, when in 
the blood, acts in a way similar to that of the P. falciparum parasite. Therefore, the same 
artemisinin based drugs can be used to treat both species of parasites.
57
 The problem with P. 
vivax is that these drugs are not effective against the hypnozoite liver stage of the parasite.  
There is a drug currently in use called primaquine that was developed from quinine in the 
40s and 50s, which has been found effective at killing P. vivax hypnozoites.
58
 However, this drug 
must be taken religiously for 14 days. Such a rigorous schedule can prove challenging to enforce 
especially for patients who don’t feel ill since they don’t have the active blood infection. 
Additionally, and admittedly the more worrisome concern about primaquine is that if taken by a 
patient with a genetic condition glucose-6-phosphate (G6P) deficiency it will cause hemolysis or 
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the bursting open of red blood cells.
59
 Therefore, since there is no quick, easy field-test possible 
to check for G6P deficiency, the broad treatment of an affected region with primaquine in the 
hopes of destroying the latent liver stage parasites could be dangerous. The exact reason why the 
drug causes such a reaction in the erythrocytes of people with G6P deficiency is unknown, which 
leads to the last concern with this treatment. The mechanism by which it works is not well 
understood, nor does much data exist on dosage recommendations, efficacy, or resistance.  
There is hope, however, in a new drug called tafenoquine, currently in clinical trials, 
which would be a single dose treatment to kill the liver hypnozoites. It is the first new drug that 
has been developed for P. vivax specifically in the past half century.
60
 In fact, it was originally 
developed in the 70s and shown to be safe for treatment, but due to a loss of interest in treating P. 
vivax, it was abandoned until recently. Unlike primaquine, this new drug would only require a 
single dose in combination with drugs to ensure the treatment of the blood stage parasites. 
Furthermore, in clinical trials for effectiveness against the standard treatment of primaquine 
preformed in Brazil, India, and Thailand (all places where P. vivax malaria is endemic) showed 
that 90 percent of those receiving tafenoquine were relapse free after 6 months compared to 24 
percent of those receiving primaquine.
61
 However, for the same reasons as primaquine, it cannot 
be used in anyone who has G6P deficiency.  
Thus, even though during the past half century there has been a lack of research and 
investment in the treatment and prevention of P. vivax, there have many some encouraging 
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developments in recent years and a renewed enthusiasm for pursuing the eradication of P. vivax 
along with P. falciparum.  
 
Why is all this important? 
 Malaria is a complex parasitic disease that affects hundreds of millions of people each 
year. The more we can understand about how it works inside the human body and in the outside 
environment, the more effective our treatments and prevention strategies can become. This is not 
the whole story though. In many areas where malaria is endemic, the understanding of this 
disease is very different from the biochemical and medical driven view of the higher income 
countries creating a problem in situations where international aid groups are attempting to treat a 
population.  
One way to bridge these diverging views on disease and illness is to understand the root 
of what is happening in affected patients. This understanding can then be applied to the 
symptoms described by patients and provide a better background for interpreting their 
perspective of the disease. Therefore, instead of dismissing a different culture’s understanding of 
a disease because it is not “medically correct”, there can be communication and new insight on 
both sides about what the disease is and how best it can be treated.  
 In fact, without communication between those who come from different cultures and 
have diverse understandings of disease, we may not have developed the medications currently 
available to treat malaria. Both quinine and artemisinin were herbal remedies used for hundreds 
of years by the native people of the lands they come from before being introduced to European 
explorers during the 15
th
 to 18
th
 centuries.  
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 With this perspective, in this next section, I will be delving into in depth case studies of a 
malaria endemic region: the Amazon Basin of Ecuador. So as to understand the dynamics of the 
disease and the populations it is affecting in the fullest way possible, I am beginning the case 
study with an introduction to the history, socioeconomic climate, and healthcare situation of 
Ecuador itself. Each of these factors plays a role in the understanding, acceptance, and 
management of a disease such as malaria.  
 Throughout this case study, I will focus especially on the healthcare available to malaria 
patients through the avenues of governmental organizations, local healers or medicine 
men/women, and foreign aid groups. In many ways, the relationship between these caregivers 
and their patients is a two way street. The types of care available to patients help determine their 
understanding of disease. However, the perception of malaria by the patient also contributes to 
his or her opinion of healthcare organizations/workers and his or her acceptance of their care. 
Each of these entities is pursuing a unique mission, encounters different challenges, and holds a 
distinct place in the opinions of their patients.  
 I realize that the region I selected is not commonly thought of as a hotspot for malaria, 
this is intentional. Malaria in the Amazon Basin is quite different from the disease in Sub-
Saharan Africa, which is so often under the spotlight. From the strain of parasite, to the treatment 
available, to the local perception of the disease, malaria in Ecuador is a very unique situation. 
From this unique situation though, I hope to use a specific perspective of the disease – 
and the challenges it creates – as a framework for investigating general themes of cross-cultural 
medicine. It is then from these themes that we can work towards creating more generalized 
guidelines and advice for appropriate interactions between international or governmental aid 
initiatives and their patients. In order to make such guidelines, one must fully comprehend the 
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condition of those affected. This means looking not only into the disease, but also the living 
conditions, social and political climate, and perspectives on health, illness and medicine of the 
patient involved. 
Ecuador: A Case Study 
Background: The Social and Political Climate of Ecuador 
The republic of Ecuador is one of many divisions. Its 15 million people represent five 
main ethnic groups and numerous subsections within these groups. Geographically, it has three 
main regions. There is the Costa, which encompasses the land between the Pacific Ocean and the 
Andes Mountains. Slightly further east and consisting of the two major chains of the Andes is the 
Sierra. Finally, the Oriente, which contains about half of Ecuador’s land, is composed of the 
Andean piedmont and the eastern lowlands of the Amazon Basin.
62
 The geographic divisions 
serve as a metaphor for the numerous societal partitions and factors, which combine to set the 
stage for socio-cultural, economic, and healthcare disparities as well. These factors are the 
intense stereotyping of the rural, indigenous population, the political and economic instability of 
the country as a whole, and the limited public healthcare system.  
 
 
Map of the Amazon Basin: About 
half of Ecuador’s land is considered 
part of the Amazon Basin and is 
characterized by a majority 
indigenous population and extreme 
poverty. 
 
 
 
 
There exists a sizeable gap between the income levels, living situations, and healthcare 
accommodations of Ecuadorians living in Quito and those, many of whom are of indigenous 
heritage, living in the remote Amazon Basin.  However, due to the averaging of data for country 
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level reports, the disparities between urban and rural settings and colonist and indigenous groups 
is often masked. For example, though Ecuador has made some great progress in health outcomes 
such as the reduction of maternal and infant mortality and childhood malnutrition, the chance of 
mortality for the indigenous population is 30 percent higher and the child malnutrition rate is two 
times higher than that for nonindigenous Ecuadorians.
63,64
 Discrepancies such as these are 
paralleled in the economic, social, and political situations of the indigenous and colonist groups 
in Ecuador. While to some, they may be counted as a byproduct of the society; these inequalities 
have much deeper roots. 
Inequalities in Ecuador date back to the early 20
th
 century along with the birth of the 
Ecuadorian Republic, which gained independence from Spain in 1830. During this time, the 
colonists and natives in the Sierra region coexisted. The highland natives were “considered 
capable of cultural transformation (i.e. overcoming their “Indianness”).”65 In the eyes of 
colonists, these “Indians” were not responsible for their race and thus, received the pity and 
assistance of the state. The natives of the Amazon Basin – or lowlands – were a different story, 
however. They were perceived as savage, meddlesome, and a completely backwards society 
incapable of redemption in the way that their mountain dwelling counterparts were.  
Since that time, many Ecuadorian intellectuals and politicians have tried to argue that 
racism in the country has died out. Empirical studies of Ecuadorian society suggest otherwise 
though.  Numerous studies conducted throughout the 1990s observed the structural racism 
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against the indigenous through mass media, education, and in public spaces. Additionally, the 
indigenous population’s public activism against this racism, and its campaigns for equality have 
earned native Ecuadorians the labels “disrespectful Indians” and “suddenly violent Indians”.66 
The perpetuation of these negative views on the humanity, morals, and personal qualities of the 
indigenous people of Ecuador demonstrates the degree to which this discrimination has been 
normalized.  
While not every Ecuadorian may be actively enforcing these harsh stereotypes, a majority 
of them are keenly aware of racial distinctions. This awareness is possibly most notable in 
Ecuadorian Spanish where there are numerous words for those of mixed heritage depending on 
how “white” or “Indian” a person appears. Those who are labeled “mestizo” or “mestizaje” have 
a lighter skin tone and these names come with a more positive connotation. On the other hand, 
designations such as “longo”, “cholo”, “guangudo”, or “indio” are reserved for people of mixed 
race who are of a lower class and who have darker skin.
67
 These qualities, skin tone and social 
class, are not necessarily always linked, but due to the stratified nature of the Ecuadorian society 
and the structural reinforcement of such social divisions, they are often seen as connected.  
Though Ecuador does have a representative government in which the indigenous 
population has been taking on an active role, the instability of leadership has contributed to the 
countries overall poverty and hardship. The country’s leadership has changed hands 13 times 
since 2000.
68
 Along with the fact that many major industries within the country including the 
petroleum industry, the export of which makes up one third of Ecuador’s overall GDP, are under 
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state control, this volatility in the government has contributed to the extensive poverty and 
economic stagnation throughout the country. Due to the mishandling of several economic 
downturns and the fall of petroleum prices in the 80s and 90s, Ecuador has spent the last decade 
rebuilding it’s economy and therefore, leaders have had little time or resources to devote to 
public health or indigenous rights.
69
 
Deeply ingrained stereotypes along with political turmoil have contributed to the 
disparities in healthcare, resources, and representation experienced by the indigenous people 
living in the rural Amazon Basin. With language that so separates indigenous from colonists, it is 
much easier to minimize and ignore the inequalities and struggles faced by the disadvantaged 
population. Additionally, since issues of the economy consume those in power there has been 
little focus on assisting the poorest of the poor who reside in the rural Amazon Basin.  
 
The Amazon Basin: The States of Health and living 
The inequalities confronting many rural inhabitants begin in many areas, with a lack of 
access to basic amenities. For example, in the rural areas of Cotopaxi, which comprise about 2/3 
of the province, almost 70 percent of people live in houses with dirt floors, 30 percent have no 
access to a toilet or latrine, and 90 percent still burn wood for cooking. Along with less than 
modern living conditions, the demographic of rural populations in Ecuador is strikingly different 
than that of the urban environments. The age distribution in these areas mirrors that of 
developing countries with a majority of the population in the younger age brackets and less than 
20 percent over the age of 40. Finally, 40 percent of those interviewed from Cotopaxi indicated 
that they had to travel an hour or more to reach a health center, which forces many to rely 
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primarily on self-care or family member care.
70
 While these statistics may draw from only one 
region of Ecuador, they represent the plight of many who live in the rural Amazon Basin where 
limited access to resources and high poverty levels are domineering factors in the determination 
of their standard of living.   
Since many communities in the Amazon Basin are extremely isolated, travel to the 
nearest town with a medical center may take up to a day. Therefore, because of their remoteness, 
patients often turn to a village medicine man or shaman for medical treatment. In fact, according 
to a 2009 estimate by the WHO, around 80 percent of people living in developing countries 
depend on traditional medicine for primary healthcare.
71
 Shamans or medicine men are members 
of the community who are usually well known and trusted. Their knowledge of traditional 
remedies ranges from ritual cleansing ceremonies to medicinal plants to the use of amulets for 
healing and protection. Most treatments are preformed with the goal of restoring balance 
between the patient and his or her surroundings.  
Because local shamans are an integral part of their communities and in most cases 
heavily respected, patients place a great deal of trust in their opinions and treatment 
recommendations.
72
 Their knowledge, which has been passed down through generations is also 
entrenched in local spiritual beliefs giving it even more authority.
73
 However, the intense trust 
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patients often have in local medicine men can become problematic if a remedy they are 
recommending is not helpful or may even be harming the patient further.  
Since the utilization of local traditional medicine for healthcare is a result of a community 
lacking access to health clinics or hospitals, exact data on the number of people utilizing these 
authorities for health problems, how hard resources are to come by, and how well treatments 
actually work is sparse. Nevertheless, from what we do know about local traditional medicine 
providers, we can clearly see two important characteristics, which dramatically affect the their 
utilization. The first is that patients have extremely high levels of trust in local shamans because 
people of the community know and respect these medicine men. Additionally, the medicine men 
understand the local culture, spiritual beliefs, and social climate allowing them to better 
understand their patients’ ailments. Both of these factors contribute to a preference for local care 
in many remote villages and higher rates of compliance with recommended treatment plans than 
is seen in either government or NGO clinics.  
The other two major healthcare providers in the Amazon Basin region bring in modern 
medical care to a portion of rural communities. The first is funded by and under the control of 
the Ecuadorian government and is called the Ministry of Public Health (abbreviated MSP for the 
Spanish name: Ministerio de Salud Pública). The other major healthcare providers are 
international aid groups, which set up clinics and bring physicians from their home countries to 
exam patients. Within this subsection of medical providers, there exists a large range of 
operational strategies. Some groups will come for a short time bringing medicines and physicians 
and then leave. Others will set up long term clinics offering basic services and assistance in order 
to help fill in the gaps in local and national health care services. Still others use a combination 
approach with physicians and medical supplies being sent down at regular intervals, but also a 
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team remaining in the country to assist with referrals to hospitals, training of community health 
workers, and assessment of the needs of the communities.  
After a brief overview of the Malaria in the Amazon Basin and the Quechua perception 
of the disease, I will investigate these outside healthcare providers more in-depth taking into 
account their treatment strategies for malaria. Additionally, for the purposes of remaining 
succinct, I will be focusing on just one aid organization, Foundation Human Nature. This 
organization follows the combination model with both periodic clinic visits and sustained on the 
ground support.  
 
Malaria in the Amazon Basin 
The status of the malaria epidemic in rural Ecuador is rather hard to fully understand 
owing to the limited number of cases that are accurately reported. Since a large portion of the 
rural population is isolated from hospitals or clinics that have the ability to diagnose a malaria 
infection, there are likely more infections than official reports suggest. Additionally, the major 
malarial strain present in the Amazon Basin is Plasmodium vivax, which is characterized by 
recurrent episodes of symptoms after the initial infection subsides. Therefore, the treatment of 
malaria as a one-and-done disease neglects the social, personal, and lifestyle effects that a 
resurgent infection can cause for patients and populations leading to a mischaracterization of the 
burden of disease caused by this parasite.  
However, despite these critiques, knowing the reported data about infection and treatment 
rates can be helpful in assessing the status of the disease. In 2010, there were an estimated 2,222 
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cases of malaria in Ecuador.
74
 This number has been dropping steadily over the past decade, 
though. In 2007, the number of malaria cases stood at 9,863.
75
 Thanks to a diligent effort through 
programs by the National Center for Malaria Education (NCME) there has been an increased 
focus on preventative measures such as the spraying of DDT and presumptive treatment. These 
actions, along with greater education about safety measures, have proven effective in drastically 
reducing reported infection rates.  
While the number of cases is nowhere near the 1.4 million in India, this does not negate 
the malaria problem in Ecuador. There exist several challenges unique to the area, which create a 
situation that is about more than just case numbers. The first of these challenges deals with a 
phenomenon in disease transmission called hypoendemicity.
76
 When a disease is hypoendemic, it 
has an incidence rate – the rate of development of new cases – that is consistent but still too low 
for a population to develop any immunity to the disease. In contrast, within the malaria endemic 
regions of Sub-Saharan Africa, malaria is so common that since it is generally a survivable 
disease (except in young children, pregnant women, and immunocompromised individuals), 
most people have had the disease and thus have developed partial immunity against future 
infections lowering the burden of recurrent adult infections. In Ecuador, however, malaria affects 
a decent percent of populations, but not everyone. Hence, there are still individuals from every 
age group who can become infected for the first time, creating a bigger disease burden for adult 
infections in the Amazon Basin. 
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Secondly, a great number of malaria cases are likely not reported or even known to be 
malaria. Since the Amazon Basin is a vast geographical area, many of the people who live there 
are isolated and are either unable or unwilling to travel to a clinic for treatment. When surveyed, 
over half of the people living in these remote villages said they were more likely to enlist the 
help of a family member or care for themselves in lieu of traveling to see a physician or nurse.
77
  
This resistance to engage in services offered by either the government or aid groups could be due 
to a number of different factors including inability to travel the distance to the clinic, preference 
of being treated at home by family or a local healer, or the inability to treated at clinics due to 
overcrowding or staff incompetence. Without appropriate infrastructure in place and 
advertisement of services, these people will continue to rely on the people and treatment methods 
they have always trusted.  
The final main issue paying into the complicated nature of malaria in Ecuador is the fact 
that the most prominent and active strain here is P vivax, which makes up over 90 percent of the 
reported cases.
78
 Because P. vivax preferentially invades liver hepatocytes delivering subtler and 
sometimes delayed symptoms, infections are harder to recognize and characterize leading to an 
underestimation of disease burden. Also, the tendency for relapse in P. vivax infections creates 
new complications because individuals assumed to be cured of infection might still exhibit 
symptoms or have complications involving other opportunistic or endemic infections. These 
factors, along with inconsistent use of government medical facilities combine to make the actual 
burden of malaria difficult to determine and total treatment even more difficult to complete.  
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So, while malaria in Ecuador may not get as much publicity or notice as that in parts of 
Sub-Saharan Africa or India, it is equally relevant both to this discussion of disease perception 
and to the international health community.  
 
Perception of Malaria by the Quechua People of the Amazon Basin 
 In the western world, we are taught to think of infections and disease in terms of germ 
theory where disease originates from microorganisms that invade the human body and affect 
normal body function causing outward symptoms. In a community with no access to technology 
such as microscopes to see these disease causing microorganisms with, the concept of illness and 
medicine take on a new meaning.  
 For the Quechua of the Ecuadorian Amazon Basin – the largest indigenous groups in the 
Americas who span Peru, Bolivia, and Ecuador – illness in the traditional understanding, 
represents a disruption of the soul and its relation with others.
79
 It relies on the detection of 
physical symptoms instead of blood tests or pathogen cultures.  
Here, instead of the categories of viral, bacterial, fungal, or parasite infections, there are 
only three types of illness. The first is called Unkay. This category of illness is due to natural 
causes such as dampness, too much heat or cold and is used to describe most general physical 
ailments. Next, there is Pahu, which is due to supernatural origins such as mythical or spiritual 
entities that have been disturbed. Finally, there is Wiruti. Literally, this word is the name of a 
blowgun dart used for hunting. Fittingly, this type of illness is thought by the Quechua to be a 
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physical manifestation of shamanistic wielding power with the intent to harm another as a 
consequence of underlying conflicts between villages or ethnic groups. 
80
  
Where an illness falls within these classifications is based upon the observed symptoms 
and will determine the appropriate treatment. Therefore, it is not uncommon for two afflictions 
that would be considered just different types or stages of a single disease in the modern medical 
world to be considered completely different illnesses for the Quechua people because they 
exhibit diverse symptoms.   
Consequently, malaria is actually characterized as two very different diseases by 
Quechua shamans depending upon the severity and the types of symptoms exhibited.
81
 In fact, 
this dual characterization of malaria based on symptoms displayed is quite common in isolated 
communities throughout the world who are affected by endemic malaria. When the malaria 
infection is nonlethal it is considered chukchu unkay or “shaking illness” in Kichwa (the 
language spoken by the Quechua). However, if malaria causes death, it is placed in a different of 
the three main categories - wiruti.
82
  
In the case of chukchu unkay, malaria is thought to be caused by an excess of cold, a 
natural and personal cause, and is treated thought medicinal plants.
83
 On the other hand, wiruti, 
because of its severity, is attributed to outside forces – spiritual in origin or a shaman from 
another village – and predatory intentions. This distinction of an external cause results in very 
different treatments from those of chukchu unkay. For wiruti there are two possible interventions. 
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The first is to conduct a search for a ritual interpretation, which often involves a ceremony 
preformed by a shaman to call upon spirits for an answer to the illness. Another option is 
political intervention, often meaning war, if the illness is judged to be the result of a malicious 
attack by outsiders from another village.
84
  Such a reaction can be seen throughout the history of 
the region in the coincidence between malaria outbreaks and sociopolitical tensions escalating to 
violence.  
The existence of such a wide variety of treatments for illness in the Quechua medical 
culture pays homage to their complex and holistic views of health. For the Quechua, the concept 
of wellbeing encompasses not only the relationship between individuals and their bodies, but 
also social relationships with both human and non-human entities.
85
 This inclusive definition of 
health and wellness, then influences the way the Quechua culture perceives illness as well. They 
are very aware of the world around them – both physical and spiritual – and as a result, can be 
very sensitive to changes in their body and environment. 
Everything about the way disease is described in Kichwa revolves around the feelings 
and experience of being sick. Most translations of symptoms are very literal as opposed to the 
medicalized terms used in modern medicine. For example, fever is rupa meaning simply “hot 
sensation”; weakness is translated as shunku nanay meaning “hurting heart” because for the 
Quechua, the heart is considered the locus of the soul and source of energy; and weak or 
darkening vision is yana rikurin, which literally means “it looks dark”.86 The Quechua look at 
illness through the lens of experience because that is what they know. They have no way to 
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connect the feelings that accompany sickness to underlying microbial causes as modern medicine 
does through immunology or microbiology.  
Such an interpretation of illness is far from incorrect. In fact, both the Quechua and 
western perspectives tell complementary sides of the same story. Yes, the Quechua may 
understand symptoms by experience and thus possibly misattribute the cause of a symptom that 
occurs in many different diseases. However, their very detailed perception of feelings may allow 
them to more accurately describe the type of pain they feel when in western medicine the many 
diverse feelings associated with pain are often lumped into only one or a few categories. If taken 
together however, these two perspectives could give valuable insight for both parties on a more 
complete picture of the disease works and is affecting the patient.  
The benefits of diverse perspectives on disease do not end at description and diagnosis. 
Great potential for new malaria treatments lies in the experience and knowledge of Quechua 
medicine men and women. For centuries, they have used medicinal plants to treat malaria 
symptoms, and one of these original plant based remedies is in fact the root of the first major 
antimalarial drug, chloroquine.
87
  Additionally, 11 of the 15 drugs currently on the market to 
treat malaria have direct connections to natural products.
88
 With drug resistant strains of malaria 
looming on the horizon, the need for new and unique antimalarials is growing. Since cinchona 
bark – from which quinine was derived – is only one of many medicinal plants commonly used 
in Quechua medicine, scientists have begun to analyze other plants used in traditional malaria 
remedies for bioactivity against both Plasmodium species.  
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In the case of drug development to avoid resistance, the world of traditional medicinal 
plants offers much to be hopeful about. Worldwide, there are over 1,000 plant species that have 
been used for their suspected antimalarial properties for centuries.
89
 While not all of these plants 
will lead to the development of a new safe and effective drug for malaria, they can provide 
researchers with a strong chance to find at least a few more drugs that can prevent the explosion 
of new cases that comes with the development of drug resistance. And in order to start analysis 
on these plants, researchers must start by talking with those who use them so as to understand the 
natural conditions, dangers, and potential of these traditional medicines.  
Through comparison of the Quechua perception of disease above to the western medical 
perspective from the disease profile, it is obvious that the two diverge on many counts. If each 
perspective remained contained within its own sphere, their differences would not pose a 
problem. However, the Quechua do not live in isolation from the rest of Ecuador nor the rest of 
the world. They come in contact with outsiders regularly, often in the form of medical brigades 
or clinics. Encounters like these give ample room for a clash of perspectives, which can have an 
effect on the care outside groups are trying to provide and the overall relationship between the 
Quechua and these outsiders.  However, before delving into the effects of divergent perceptions, 
lets take a look at the different circumstances – specifically those concerning malaria – under 
which groups of indigenous people come into contact with the outside world  
 
Government Interventions and Healthcare 
Initiatives for malaria treatment in the Amazon Basin can be at best described as a 
patchwork of efforts through the three main healthcare entities: state services, international 
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organizations, and local healers. Even so, there are still areas that remain without access to 
treatment.
90
 It is widely known both in Ecuador and throughout the international healthcare 
community, that the government sponsored healthcare system has many gaps that the state seems 
unwilling to fill. Their unwillingness to improve malaria treatment programs is due to both a lack 
of available funds and a still persistent bias against the indigenous and mestizo people of 
Ecuador who make up a large majority of the people affected by malaria.  
Nevertheless, government efforts do play an undeniable role in the fight against malaria 
in Ecuador. Currently the main government program is the NCME (National Center for Malaria 
Eradiation). This program constitutes a national effort to improve malaria protection via 
increasing the use of controlled strategic spraying of DDT, more accurate case detection, and 
presumptive treatment.
91
 Government run hospitals and clinic facilities scattered throughout the 
region in province capitals provide such services. These major towns usually house a population 
of less than 1 million individuals, so are still quite small.
92
  
At NCME centers, patients are seen by doctors, nurses, or other health workers 
depending on the availability of providers. These facilities provided passive detection of malaria 
through Rapid Detection Tests (RDTs). Such tests are useful in remote and resource poor 
locations, as they do not require microscopes or skilled laboratory technicians to interpret. RDTs 
can use blood from a finger-stick and rely on the reaction of the test strip with components that 
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are present at abnormal levels in malaria parasites compared to normal human blood.
93
 These 
RDTs are fast, cheap and easy making them ideal for use at clinics in the resource poor Amazon 
Basin especially when used in conjunction with a physical examination. While not as accurate or 
sensitive as traditional microscopic analysis, they are for practical purposes effective enough for 
field treatment. Most times, patients arrive at clinics after progressing to the symptomatic stage 
of the disease when the parasite concentration in their blood is likely above the threshold needed 
for detection by RDT.
94
  
The other main services provided by NCME centers are treatments in the form of 
antimalarials for those who test positive for the parasite, preventative treatment for high-risk 
groups such as pregnant women and children if supplies are sufficient, and DDT spraying for 
surrounding communities.
95
  
Unfortunately, because of the difficult terrain and isolated population, the government 
facilities are not easily accessible to a majority of people residing in the Amazon Basin region. 
Only those who live close to a major town or have access to reliable transportation are able to 
benefit from government programs meaning that a significant number of people never come into 
contact with government treatment and prevention efforts. 
If a significant portion of Amazon Basin residents can’t access Ecuadorian government 
healthcare facilities, this also means that the government estimates of the malaria infection rate is 
severely inaccurate. In a study conducted over the span of 4 years in the 1990s, data confirmed 
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that the cases of malaria confirmed by the NMCE made up less than half of the overall reported 
cases, which in turn represent an undetermined portion of all malaria cases in Ecuador.
96
 This 
underestimation of the malaria endemic by the Ecuadorian government not only instills a false 
sense of security in regards to malaria risk, but also results in an inappropriate amount of funding 
being directed toward malaria control.  
All services provided by the NCME centers are funded through the Ecuadorian 
government. Thus, due to inaccurate estimations of disease prevalence, this funding, while 
reliable, is not necessarily sufficient to meet the needs of the areas NCME centers serve. 
Shortages of staff, medicines, and testing supplies are common, and there has been little if any 
movement within governing bodies to increase funding for the program.  
For patients that are able to come to and receive treatment at the NCME facilities, 
opinions of the healthcare provided are mixed. A study conducted in 2012 on the perceptions on 
healthcare facilities of rural Ecuadorian residents, found that most were grateful for the 
opportunity to get correct and helpful medicine, but were dissatisfied with the quality of service 
at clinics.
97
 Many patients, especially to those who had had contact with western doctors working 
with international NGOs, expressed that the doctors at government clinics overall had negative 
attitudes and seemed younger and inexperienced.  
The attitudes and experience levels of doctors in these rural settings is likely a direct 
result of a mandatory program in Ecuadorian medical education where first-year physicians (who 
would be first-year residents in the United States system) are required to spend a year serving in 
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one of these rural clinics.
98
 Often, these young doctors are on their own as the only medical 
professional working at the clinic. Their U.S. equivalents, on the other hand, work under and 
learn from a team of experienced, senior doctors for a few years after graduating from medical 
school.  
The practice of placing new and inexperienced doctors that have never practiced 
medicine before alone in an isolated setting to learn on the job while treating patients is 
representative of the governments attitude towards rural health overall. They provide some 
services, but efforts to improve conditions are only half-hearted, still leave behind many gaps in 
healthcare coverage, and even those who do have access to services are often denied medicine or 
examinations due to insufficient funding and staffing of government run rural hospitals and 
clinics.  
 
The State of Outside Aid 
The other category of modern medicine providers in the Amazon Basin region of 
Ecuador is international NGOs. These organizations range from small, with have fewer than 100 
people involved, to enormous multinational strategists like the WHO or the Pan American Health 
Organization (PAHO). The exact number of organizations with a sustained presence in Ecuador 
is difficult to determine. There is not much regulation or documentation by the government or 
otherwise of what international groups are currently active within the country. The regulation 
that does exist is enacted mostly through political interest. In 2012, Ecuador’s Secretariat for 
International Cooperation revoked operation permits for 26 foreign NGOs and tightened 
restrictions on 15 others because, according to president Rafael Correa, these groups were 
                                                        
98
 Biermann, Olivia, Bringer Forsburg, and Martin Eckhart. Perceptions of a Non-governmental Organisation and 
Its Health Care Services by a Marginalized Population in Rural Ecuador. Thesis. Karolinska Institute, Sweden, 
2012. N.p.: n.p., n.d. Convibra Health Congress Online. 2012. Web. 
 53 
“extremely right wing” and attempting to “replace the government and impose their politics”.99 It 
was not clear exactly how many, but at least a handful of the banished NGOs were preforming 
health services. Additionally, in the past, the Ecuadorian government has been known to shut 
down NGOs accused of supporting indigenous protest against mining and drilling projects. Since 
most health NGOs work with indigenous communities, and some have asserted that resurgence 
of malaria may in part be caused by the environmental effects of rainforest destruction, some of 
these shutdowns inevitably left whole communities without medical care.  
On the issue of malaria, many of the NGOs working in Ecuador are simply implementing 
the recommendations of larger multinational initiatives including Roll Back Malaria – the result 
of the partnership of many international health organizations primarily the WHO. These larger 
organizations are able to dedicate time and money to fund research on malaria treatment and 
prevention, which they then use to develop action plans specified to the different areas of 
endemic malaria. This way, individual NGOs can focus on the best way to optimize 
implementation in their specific area while the larger organizations focus on ways to optimize 
the treatments that are given.  
Since Ecuador is considered a low transmission area primarily infected with P. vivax, the 
strategy recommended by the Roll Back Malaria initiative stresses the use of prevention methods 
such as vector control through insecticide spraying is touted since transmission in the Amazon 
Basin is seasonal and intimately linked to the mosquito population. Roll Back Malaria also 
advises the implementation of localized and early diagnosis through parasitological exams and 
RDT. Little immunity to malaria exists within communities of the Amazon Basin causing 
infections to be devastating to those who contract them. As for treatment, they recommend the 
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use of a 14-day regimen of chloroquine in combination with primaquine.
100
 Unfortunately, 
because P. vivax in most areas of the Ecuador has developed resistance to chloroquine, the 
treatment regimen has been altered to recommend artemisinin-based combination therapy (ACT) 
instead, which is more expensive.
101
  
These recommendations are then carried out by smaller NGOs targeting specific areas for 
which to provide care. Foundation Human Nature (FHN) is one such NGO. Established in 2003, 
after a severe outbreak of cerebral malaria, FHN serves about 6,000 people in village of La Y de 
la Laguna and surrounding areas that would otherwise have to walk up to 10 hours to reach the 
next nearest health clinic.
102
 La Y lies in northern Ecuador and technically at the far western 
edge of the Amazon Basin. However, its population is extremely poor and isolated similar to 
many communities in the east – which is better known as part of the Amazon Basin. Also, 
though the region is slightly higher in elevation, its climate is still more similar to that of the 
rainforests than the sierra. FHN is based in Germany and provides funding for the Ecuador 
initiative, which they call the Minga Foundation.  
When the organization first came to the area of La Y, there was no official map, travel 
into and out of the region was exceedingly difficult – this was part of the reason there was only 
marginal government support for the people living here. A majority of the population of the 
region consists of people of mixed, African, and indigenous decent. Additionally, outside of the 
village of La Y, the people have no access to clean drinking water, garbage disposal, electricity 
or educational facilities.
103
 In terms of health risks, the region is plagued by a high susceptibility 
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to malaria as well as dengue fever, typhoid, and intestinal parasites.
104
 Due to their extreme 
isolation, these people had been neglected in all public health outreaches by the Ecuadorian 
government.  
FHN has sought to improve both health and living conditions in La Y and surrounding 
regions through an Ecuador-focused project called the Minga Foundation. Their mission is to 
help communities to achieve better socioeconomic and health conditions through partnerships 
and the empowerment of community members to invest in the future of their own community.
105
 
The Minga Foundation places emphasis on the training of local individuals as community health 
workers (CHW), and recruits doctors and nurses from Ecuadorian medical schools in order to 
achieve collaboration on many levels. In fact, “Minga” is an indigenous Quichua term that means 
“collaborative work through which friends and neighbors volunteer time, effort, and resources to 
achieve a shared goal for the betterment of the community.”106  
Services provided by the Minga Foundation are centered on El Subcentro de Salud. The 
facility provides a medical clinic staffed by Ecuadorian doctors and nurses in their year of rural 
service; a training program for CHWs; workshops for local people on topics such as hygiene, 
family health, vaccination campaigns, first aid, and domestic violence; a waste management 
project; a medicinal plant garden; the region’s first library; and periodic medical brigades to 
smaller communities with foreign volunteer medical staff.
107
 Specifically for malaria diagnoses, 
the health clinic has been able to offer RDT testing, antimalarials, and community workshops for 
malaria education.  
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Until 2010, FHN and the community jointly managed El Subcentro’s daily operation and 
special initiatives. However, since then, the clinic’s daily functions has been independently run 
and financed by the community. FHN still provides financial and organizational support for 
special projects and medical brigades, allowing for the expansion of services in this high need 
area. This also creates space for greater community ownership of and investment in their own 
healthcare. Ultimately, these two qualities will hopefully allow El Subcento de Salud and the rest 
of FHN’s projects to be sustainable.  
Overall, FHN has had an overwhelmingly positive effect on the community health care in 
La Y and the surrounding areas by providing doctors, nurses, testing, medicine, health education, 
and public services that they otherwise would have not had access to. Also, malaria, which was 
once a major cause of death in the area, has now been controlled through robust testing, 
treatment and community education. The real test, however, remains the acceptance of this care 
by the community. In a 2012 study, the community of La Y was surveyed about their 
experiences at the health clinic and their satisfaction with FHN and its services.  In general, most 
patients expressed gratitude for the organization and the people working there both international 
and Ecuadorian. They appreciated that services were offered free of charge and liked the fact that 
medical brigades periodically trekked out to further communities bringing doctors and medicine 
with them.
108
 The overall attitude towards the organization and the health clinic was 
overwhelmingly positive. 
However, as with any project, people did express some complaints or suggestions of what 
they wanted to see from the NGO. The biggest complaints by residents of La Y and the 
surrounding areas were not enough medical brigades or doctors, misunderstandings of who funds 
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and runs the health center, misunderstandings of the role of CHWs, and foreign doctors didn’t 
spend enough time in the community to understand the culture and health situation there.
109
 
Given the fact that FHN is an international organization, many of these complaints are expected, 
as there are troublesome language and cultural barriers that must be navigated for maximal 
understanding on both sides. 
So, while they are not perfect by any means, FHN and their Ecuador project, the Minga 
Foundation, have been implementing some great strategies for distributing health care, educating 
the population they serve about malaria among other health concerns, and working with the 
government of Ecuador and the local communities to insure the correct, sustainable, and 
effective use of medical resources.  
The healthcare situation, specifically in regards to the treatment of malaria, in the 
Amazon Basin of Ecuador results from a complex slew of geographical, historical, cultural, 
economic, and international factors. Each individual branch of Ecuador’s current rural health 
system has its strengths and weaknesses, and thanks to recent initiatives especially in the fight 
against malaria, collectively they have begun to reach more people in the rural, isolated Amazon 
Basin. However, there is more that can be done, and there is more that needs to be done in order 
to continue the trend of reaching more patients and successfully treating them. 
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A Collision of Perspectives: An Analysis 
Thus far, I have covered two very distinct characterizations of the same disease. One, the 
dominant perspective taken in the modern medical world, emphasizes the mechanisms of the 
malaria parasite and their specific effects on various body systems. The other, Quechua medical 
tradition, focuses on the experience of the illness. Here, symptoms, severity, and a patient's 
connection to the world around them dictate the Quechua understanding of this same disease. 
Both approach the disease from different angles, with different a base of knowledge, and armed 
with different treatments. And yet, both methods of diagnostics and treatment are effective in 
their own ways.  
 At times the nature of how modern medicine and science attempt to understand the world 
can cause us to lose the big picture or key points in pursuit of intimate details. We are so 
obsessed with finding out every aspect of how a disease progresses and affects every system of 
the body that we sometimes forget there is a subjective component to disease as well. This 
personal experience of illness, which the Quechua base their medical system on, can affect 
treatment and prognosis as much as much as antimalarials via factors such as early diagnosis 
through subtle symptom detection, holistic treatment, and the provision of unique and possibly 
revolutionary medicinal plants.  
 If an international aid group attempts to impose a certain medical perspective on patients 
who have lived their whole lives through a different perspective, they will encounter more 
problems and resistance than successful treatments. For the most part, people will not blindly 
follow treatments, especially if their own medical knowledge is contradictory. In order to 
actually benefit the community, they must be involved in the decisions about their care. The only 
true way to achieve this is through collaboration. Therefore, after examining and validating the 
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unique strengths and weaknesses of each viewpoint, I now present my case for the benefits of a 
cooperative approach to understanding and treating malaria around the world through mutual 
education and receptivity.  
 First, however, it is important to remember that bringing together two vastly different 
perspectives will always result in a collision of sorts. Both sides will be confronted with 
information and opinions they have no way to process, which can be extremely stressful and 
intimidating. Because of the innate stress of this process, some individuals on either side will 
also likely resist the bridging of perspectives. Therefore, it is important to acknowledge that full 
collaboration will take time and that on the way to achieving this goal, there will first be damage 
that must be repaired and trust that must be built.   
 
Collateral Damage 
Collisions, unless you are talking to a nuclear physicist trying to create nuclear fusion, 
most often carry with them a negative connotation. The meeting of two opposing forces creates 
conflict, damage, and the upheaval of stability. Similarly, in situations where outside aid – either 
from the Ecuadorian government or international – is brought into an Amazon Basin community, 
both doctors and patient are coming to the clinic with different understandings. The more 
different these views are from one another, the more possible complications misunderstandings, 
low compliance, and breaks in communication are.  
 Misunderstandings were some of the most commonly cited complaints from surveys of 
community members in La Y de la Laguna. In many cases, people were hearing information 
about the health center and FHN from secondary sources because FHN didn’t have clear 
methods of broadcasting messages to the communities. Therefore, information about the center 
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becomes vulnerable to the telephone effect where slight misconceptions are be amplified with 
each retelling eventually resulting in completely false information. The breakdown in 
communication over time between the health center, FHN, and the community lead to this 
confusion of leadership and could ultimately have some more dramatic effects in terms of patient 
trust of the medical providers and community involvement in and support of the health center.  
 If patients don’t know who they are receiving care from, they are less likely to have trust 
in the doctor and the treatment that he or she prescribes. This lack of trust can then lead to low 
patient compliance, which is a major problem especially in the treatment of diseases such as 
malaria that require a regimen of a strict determined length to fully cure the disease. The problem 
of reduced compliance is not just an issue for international NGO initiatives. It can also be seen in 
government health clinics as well. Here, studies have shown that of those who came to 
government clinics, for every three fully compliant patients, there were two at least partially non-
compliant patients.
110
   
A second hurdle commonly encountered by NGOs like FHN is low patient compliance to 
treatment. When surveyed, Ecuadorian patients’ reasons for not taking antimalarial medicine 
usually fell into two main categories. The first group included those who stopped taking 
antimalarials due to side effects of the drugs including nausea, vomiting, dizziness, and also 
those who saw symptoms disappear quickly but were not completely parasite free when they 
stopped treatment. The other major reason people stopped treatment was because they 
underestimated the severity of the disease. 
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 Both segments of the noncompliant population cite reasons that could potentially be 
mediated by better education and communication by healthcare providers. First of all, it makes 
sense that patients would stop taking a drug that is making them feel sick if they don’t know that 
is a normal reaction for some people and that it is much better than the consequences of malaria 
itself. Patients should not be expected to just blindly obey instructions given to them, especially 
if they don’t understand fundamental aspects of the treatment such as what to expect in terms of 
side effects, under what conditions the drugs should be taken, or – in the case of malaria – that it 
is essential to keep taking the drugs even after symptoms subside in order to fully clear the 
infection.  
 For those who cited underestimated the severity of the disease as a reason for not taking 
antimalarials, a general education campaign about malaria could help improve compliance. It 
seemed that in those surveyed, those who were told they had P. falciparum had a compliance-to-
noncompliance ratio of 2:1. On the other hand, those patients who were told they had P. vivax 
had a ratio of 1.5:1, and those who were told only that they had malaria in general terms had a 
compliance ratio of 1.3:1.
111
 This trend in compliance vs. noncompliance mirrors perceptions 
concerning malaria that are quite prevalent in the Amazon Basin.  
 Most people in rural Ecuador know that P. falciparum malaria is very different than P. 
vivax both from the experience of seeing someone suffer from it and from the severe symptoms 
if they have had it. Since P. falciparum is the flashier of the two strains, it is perceived as much 
more dangerous, and therefore, patients are likely to follow treatment regimens. Conversely, P. 
vivax is less virulent – has less intense and sudden symptoms – and thus, is seen as less 
dangerous and more survivable. Finally, those who are told only that they have malaria and not 
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the specific strain are likely ill informed about many aspects of the diagnosis and treatment 
process. Whether due to a misunderstanding between patient and doctor, a language barrier, or 
just an apathetic care provider, there is important information that is not being conferred to the 
patient.  
 Stepping back into the shoes of the Quechua, remember that their understanding of 
diseases, including malaria, are based upon observation of symptoms and the disturbance of the 
relationship between the body and the world around it. Consequently, wouldn’t it seem natural 
for a patient who is having adverse side effects to a drug to immediately think that he or she is 
just getting sicker because of the drug? And wouldn’t a patient whose symptoms have 
disappeared think he is cured even if he still has a few days left in his treatment regimen?  
So the problem is not that these patients in the Amazon Basin just don’t want to get better 
or aren’t concerned with their own health, quite the opposite actually. They just see health and 
illness through a different context than the world of modern medicine. Therefore, they don’t need 
to be monitored while taking medicine in order to increase compliance. Instead they need to be 
part of a conversation. They need a conversation where their opinions and views can be heard 
and understood instead of assumed ignorant of medical knowledge. They also need a 
conversation where they are taught about their condition in terms they can relate to instead of 
just given instructions in a void of context.  
A final complication encountered by international NGOs fighting malaria in Ecuador is a 
lack of cooperation with the government health system. Communication is not only important 
between patient and doctor or between an aid organization and the people they are helping; it is 
also essential for cooperation between aid groups working in the same area. One of the biggest 
criticisms of Ecuador’s public health system and its response to malaria is its patchwork 
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organization. Governmental initiatives only serve a small portion of people, and even for those 
people, there is limited funding. They rely on foreign and domestic NGOs to fill in the gaps. 
However, since there is little to no organization of NGOs working in Ecuador, it is difficult to 
know which areas are well covered, which need more care, and what care is needed by individual 
communities.  
All of these organizations, bringing with them doctors, supplies, and funds that are 
desperately needed throughout the Amazon Basin, are coming in to the country blind to what 
other organizations are already in place. While new NGOs may at least know that the area they 
serve has no other access to healthcare, they don’t know if there is another groups in the general 
area with whom they could partner to make more efficient use of resources or coordinate 
outreach into remote communities. Thus, without communication between aid groups serving in 
the Amazon Basin, there exists a very real problem of uneven treatment, and the squandering of 
already scarce resources.  
In brief, the collision of diverse perspectives on disease, health, and aid can cause some 
devastating instances of misunderstanding especially if the time is not taken for both sides to 
openly talk and listen to one another’s thoughts, feelings, and opinions. Unfortunately, the 
breakdown of communication within Ecuador’s system of public health allows us to see these 
consequences very clearly. However, much as there is never just one perspective to a 
relationship, there are not only negatives that can come from a collision. As trust is built and 
information shared, there are incredible benefits that begin to arise.  
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Impacts and Innovation  
 The word collision may inherently bring to mind negative thoughts, but what if I was to 
use impact instead? It still can be used to describe the meeting of two very different forces or 
viewpoints, but also implies a change to both parties because of their convergence. Impacts 
happen in brainstorming sessions, at schools, and in reformations. They allow us to uncover 
revelations and novel solutions. They breed understanding, tolerance, and inspiration. Finally, 
they can signal the start of a new effort for collaboration, which is exactly what is needed in the 
Amazon Basin.  
 One of the largest revelations from the clash of modern and traditional medicine in rural 
Ecuador is the discovery of new resources for antimalarial drug development. While the modern 
medical world has only 15 drugs to treat malaria – many of which belong to just two main 
classes – the Quechua have been using over 100 unique medicinal plants for centuries for 
malaria treatment. Now, their vast knowledge of medicinal plants is being tapped by top 
ethnopharmacologists, who study cultures and their use of drugs. They are learning about the 
efficacy, dangers, and traditional preparation of such plants from those who know them best in 
order to utilize this knowledge in laboratories and potentially create then next new weapon 
against malaria.  
 Their research has been promising as well. Of the plants sampled so far, there are a 
number that show some definitive antimalarial properties that could serve as a new base for the 
next class of drugs much as quinine and artemisinin did many years ago. Additionally, this 
conformation of antimalarial activity can serve as validation for the Quechua medical knowledge 
for those who might be quick to write them off as uneducated in medicine because of their 
spiritual beliefs regarding illness or ignorance of certain modern medicines.  
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 Another benefit from the convergence of different perspectives can be seen in the 
outcomes of FHN’s clinic in La Y, Ecuador. This clinic began as a joint effort between the 
community and an international organization, which encouraged community participation in 
healthcare. Then, once it became established and secure, management was transferred 
completely to the community allowing them to utilize the new resources and strategies brought 
in by FHN along with their own knowledge of the community and judgment to continue 
sustainably offering basic healthcare for the area.  
 Self-sufficiency is the ultimate goal for any aid operation. The ability to give a service to 
a certain region is great. However, it requires the constant input of funds, personnel and 
resources. If instead, an NGO can teach and enable a community to provide that service 
themselves, they can not only, become self-sufficient, but also create more jobs, empower more 
members of the community, and address specific community concerns better. It also allows the 
NGO to focus their efforts on a different challenge to further help that area or to bring their 
service to a whole new area. For example, FHN in Ecuador has now expanded its efforts to 
collect regional health and census data so that needs in other isolated communities similar to La 
Y can be recognized and addressed in the future.   
The truth is that collisions and impacts are one in the same. There will always be both 
good and bad sides in the meeting of diverse perspectives and the sooner we realize this, the 
sooner we can begin to reap the benefits of these clashes as well as focus on remediating the 
negative effects.   
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From Perception to Action: What’s the next step? 
 Observations in their own right are good and useful. However, their impact is limited if 
just taken at face value. In order to truly utilize this information on disease perception and 
healthcare, these newfound connections must be applied through progressive changes. In this 
situation, the changes that need to be made are systematic, and in order to change the structure of 
a broken system, you need a partnership. 
While the Ecuadorian government, organizations working in rural Ecuador, and 
indigenous people they are helping do not currently fit the traditional definition of a partnership; 
they have the potential to achieve monumental gains in health and international cooperation by 
working towards functioning as one. The key to a smooth cooperative partnership is to make sure 
all participants are informed, empowered, and receptive. Such a relationship starts with 
communication. 
In order to efficiently spread healthcare throughout the population, there must be 
organization of care providers. Such organization can only come as a result of communication. 
At the very least, there needs to be better communication between the government of Ecuador 
and each of the NGOs currently caring for communities in the Amazon Basin and the rest of 
rural Ecuador. This would allow groups to coordinate plans, pool resources, and ensure that all 
areas are accounted for and either being treated or will be treated in the future.  
Large partnerships of NGOs already exists including Roll Back Malaria, and Malaria No 
More, which coordinate efforts of individual organizations for research, resource acquisition, and 
strategizing for treatment. Therefore, it is not unreasonable to suggest the formation of such a 
partnership between healthcare focused NGOs in Ecuador. Furthermore, creating an alliance of 
healthcare NGOs might facilitate communication with the Ecuadorian government.  
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The other major area where improved communication is needed is in the relationship 
between healthcare providers and the communities they serve. For aid groups, improving 
communication means increasing transparency and dispelling rumors or misconceptions about 
the organization. It also entails listening to the concerns and questions of their patients. Open, 
two-way communication can help to reduce misunderstandings and lead to a more trusting 
relationship between the two parties. Ultimately, better communication can help increase the 
efficacy of treatment plans. Patients will understand their conditions and why they are given a 
particular treatment leading to better compliance with treatment. On the other side, doctors will 
understand the perspectives and living situations of their patients and then will be able to adapt 
treatment to give them the best chance of success.  
Patient-doctor conversations in rural Ecuador could also benefit from a technique 
currently being implemented by a health center in the predominantly indigenous city of Otavalo. 
The health center is called Jambi Huasi and was founded in 1994 by a local NGO in order to 
meet the unique health needs of the indigenous community. Their philosophy asserts that health 
needs can only be addressed properly in the context of their own social and cultural context. 
Consequently, the health center at Jambi Huasi offers not only a full spectrum of modern medical 
treatments but also have two full-time traditional healers on staff whose services are utilized by 
around half of the 1,000 patients per month who come to the clinic.
112
  
Jambi Huasi’s success, they believe, stems form their integration into the cultural 
traditions and value systems of their clients. They have built a medical system that respects and 
provides treatments that abide by the indigenous concept of holistic health, which sees the 
patient not only as an individual, but as biologically, socially, and spiritually linked to their 
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social and natural environment.
113
 Furthermore, even modern medicine practitioners integrate 
traditional medical concepts into their work by using them to help explain a diagnosis or 
treatment to a patient. When an unfamiliar idea such as a diagnosis is placed in familiar terms 
such as the traditional understanding of a conditions origin, the patient has a much greater 
likelihood of understanding important information the doctor is attempting to deliver.  
International NGOs could learn a great deal from the model by which Jambi Huasi 
operates. By legitimizing and providing traditional medicine as well as employing its concepts to 
convey a diagnosis, international groups could improve relations with indigenous communities, 
build trust, still reach potential patients who might be weary of modern medicine, and also 
improve health literacy. 
 Along with conversations between patients and their doctors, communication in health 
clinics can be made more effective through pubic health education programs for the entire 
community. Programs on such basic topics as hygiene, common diseases in the area and their 
remedies, and general healthy lifestyle tips could go a long way. They would not only improve 
health literacy and understanding of treatments patients might be given, but also possibly 
preempt future visits for avoidable conditions.  
 An education program could then be expanded into a community health worker (CHW) 
training class. This would allow those interested in healthcare to continue learning how to care 
for ill members of their community, and allow for members of villages further away from the 
health clinic to bring care back to their neighbors who may not be able to make the journey to the 
main health center. Additionally, the training of CHWs allows community members to become 
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involved and invested in their own healthcare ultimately lessening reliance on outside 
organizations and creating a more sustainable healthcare system. 
 Finally, increase receptivity to the cultural knowledge of local people can lead to 
immense benefits not only in a single community, or all of Ecuador, but in the worldwide fight 
against malaria. Local knowledge of medicinal plants made be the key to unlocking the next big 
class of malaria drugs. Moreover, locals can help give receptive medical providers a sense of the 
community climate, which can aid in the way they approach exams, interact with patients, and 
develop treatments.  
  These six recommendations, all centered on improving communication and respect for 
cultural differences, could help to organize and concentrate the efforts of combatting malaria and 
of providing basic health care in the rural Amazon Basin region of Ecuador. They highlight the 
importance of partnership among all players, empowerment of those in need, and receptivity to 
new ideas on all sides. These factors are crucial in allowing for equal participation in changes 
and developments throughout the system. For in order to effectively change a system you need to 
involve people living inside the system who intimately know its effects and people looking in 
from afar who can easily spot structural flaws that may be hidden from those inside.  
 But why stop at the borders of the Amazon Basin? These principles of communication 
and respect for culture can be translated into terms that apply to any collaborative medical aid 
effort whether they are in South America, Africa – where malaria is an even more prominent 
focus of medical aid, or really anywhere in the world. Every country constantly faces its own 
public health challenges, and even within a country, there exist many individuals with their own 
unique perspectives on health based on their experiences, culture, and environment. All of these 
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perspective are not only valid, but also essential to understanding the disease and the social 
burden it places on a community. 
The Aftermath: A Few Closing Thoughts 
 As human beings, we all have some concept of what health and wellness means. No 
matter our culture, we know the experience of illness and have some way of coping with that 
experience. We do not, however, all have the same concept of health. It is a concept influenced 
by our environment as well as our reactions to that environment, which very not only from 
culture to culture, but also from individual to individual. Each individual experience of a disease 
contributes a line to the definition of that disease. One perspective alone can neither describe it 
completely, nor treat it effectively.  
 For example, in Ecuador, the Quechua understanding of disease is derived not from germ 
theory, but instead from their astute perception of symptoms and their interpretation of health as 
a holistic quality. They see a person’s wellness as a product of their biological, social, 
psychological, and spiritual connections to the environment. This characterization, however, is 
also a stereotype in the sense that not all individuals within Ecuador and even within the 
Quechua peoples understand health in this exact way. While it may be true for a portion or even 
a majority of individuals, there still exists much more variety in perceptions than it is possible to 
describe.  
 In the world today, international aid is widespread. There are thousands of organizations 
and thousands of causes they represent. Through these organizations, culture collision is 
inevitable, and depending upon how the collision is addressed by both parties, it can be a true 
wildcard factor in the success or failure of the aid initiative.  
 Due to the extreme variation in individual perspective of health and the ubiquity of 
international aid, a need exists for generalized principle with which to address the cultural 
interface. Two of these principles are increased communication between parties and general 
 72 
respect and receptivity of a patient’s culture, social context, and personal knowledge. Even 
though they have been assembled from our case study of Ecuador, they are more like basic 
principles of respectful human interaction. Therefore, it follows naturally that such principles can 
be scaled up and applied in a variety of different cultural contexts around the world.  
 While it may seem unnecessary emphasize the need for respect and communication in 
interpersonal interactions, often these principles are forgotten in pursuit of a seemingly bigger 
goal such as the eradication of malaria for example. However, it is only through mutual 
cooperation in these international efforts that progress can be made. And so I will end with the 
Quechua translation of a critical principle in the world of global health.  
 
Tukuy kay pachaman paqarimujkuna libres nasekuntu tukuypunitaj kikin obligacionesniycjllataj, 
jinakamalla honorniyojtaj atiyniyojtaj, chantaqa razonwantaj concienciawantaj dotasqa 
kasqankurayku, kawsaqe masipura jina, tukuy uj munakuyllapi kawsakunanku tian. 
 
All human beings are born free and equal in dignity and rights. They are endowed with reason 
and conscience and should act towards one another in a spirit of brotherhood.  
(Article 1 of the Universal Declaration of Human Rights) 
 
